Globus Historical Cash Flow
| GMED Stock | USD 82.63 0.69 0.84% |
Analysis of Globus Medical cash flow over time is an excellent tool to project Globus Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 106.5 M or Begin Period Cash Flow of 139.2 M as it is a great indicator of Globus Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Globus Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Globus Medical is a good buy for the upcoming year.
Globus |
About Globus Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Globus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Globus's non-liquid assets can be easily converted into cash.
Globus Medical Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Globus Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.At present, Globus Medical's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 152 M, whereas Free Cash Flow is forecasted to decline to about 106.5 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Free Cash Flow | 219.4M | 104.4M | 165.2M | 106.5M | Stock Based Compensation | 30.6M | 32.8M | 52.7M | 55.4M |
Globus Medical cash flow statement Correlations
Click cells to compare fundamentals
Globus Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Globus Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (50.0M) | (50.1M) | (12.0M) | (61.7M) | (70.3M) | (66.8M) | |
| Change In Cash | 56.0M | 43.7M | (46.3M) | (42.6M) | 316.8M | 332.7M | |
| Stock Based Compensation | 26.1M | 27.1M | 30.6M | 32.8M | 52.7M | 55.4M | |
| Free Cash Flow | 101.2M | 135.1M | 219.4M | 104.4M | 165.2M | 106.5M | |
| Change In Working Capital | (73.4M) | (37.6M) | (17.3M) | (105.3M) | (116.6M) | (110.8M) | |
| Begin Period Cash Flow | 139.7M | 195.7M | 239.4M | 193.1M | 150.5M | 139.2M | |
| Other Cashflows From Financing Activities | (6.6M) | 66.0M | 54.1M | 34.5M | (6.3M) | (5.9M) | |
| Depreciation | 52.7M | 62.9M | 69.9M | 68.3M | 144.7M | 152.0M | |
| Other Non Cash Items | 7.1M | 48.5M | 61.5M | 14.7M | 97.5M | 102.4M | |
| Capital Expenditures | 70.8M | 63.7M | 56.9M | 74.0M | 78.3M | 49.9M | |
| Total Cash From Operating Activities | 172.0M | 198.8M | 276.3M | 178.5M | 243.5M | 156.4M | |
| Change To Account Receivables | (18.3M) | 10.7M | (25.9M) | (50.8M) | (49.9M) | (47.4M) | |
| Net Income | 155.2M | 102.3M | 149.2M | 190.2M | 122.9M | 117.5M | |
| Total Cash From Financing Activities | 24.4M | (38.7M) | 54.1M | (110.0M) | (231.8M) | (220.2M) | |
| End Period Cash Flow | 195.7M | 239.4M | 193.1M | 150.5M | 467.3M | 490.7M | |
| Sale Purchase Of Stock | 31.0M | (104.7M) | 63.5M | (144.5M) | (225.6M) | (214.3M) | |
| Total Cashflows From Investing Activities | (140.3M) | (117.3M) | (375.9M) | (110.4M) | (99.3M) | (104.3M) | |
| Other Cashflows From Investing Activities | (69.5M) | (20.2M) | (284.6M) | (4.9M) | (4.4M) | (4.6M) | |
| Change To Netincome | 37.5M | 71.3M | 71.9M | 22.6M | 26.0M | 34.2M | |
| Change To Liabilities | 773K | 12.9M | 26.8M | 17.6M | 20.3M | 10.9M | |
| Investments | (45.7M) | (20.2M) | (284.6M) | (4.9M) | (78.1M) | (82.0M) | |
| Change To Operating Activities | (5.2M) | 6.5M | 11.7M | (4.2M) | (4.8M) | (5.1M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 42.231 | Earnings Share 0.62 | Revenue Per Share 18.217 | Quarterly Revenue Growth 0.631 | Return On Assets 0.0473 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.